• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    8.34 Down 0.16(1.88%) Jan 30, 4:00PM EST
    |After Hours : 8.34 0.00 (0.00%) Jan 30, 5:18PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 13,467   4,119   9,795  
    Cost of Revenue -   -   -  
    Gross Profit 13,467   4,119   9,795  
    Operating Expenses
    Research Development21,369  17,985  20,032  
    Selling General and Administrative13,643  10,778  11,989  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (19,544) (23,494) (21,639)
    Income from Continuing Operations
    Total Other Income/Expenses Net(44,539)4,932  6,921  
    Earnings Before Interest And Taxes(64,084)(18,562)(14,717)
    Interest Expense -   -   -  
    Income Before Tax(64,084)(18,562)(14,717)
    Income Tax Expense -   -   -  
    Minority Interest55  44  51  
    Net Income From Continuing Ops(64,028)(18,518)(14,666)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (66,028) (19,669) (15,253)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (66,028) (19,669) (15,253)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.